ANDREA KING: Open Payments
NPI 1699189571 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 4 | $214 |
| ARGENX US, INC. | 2 | $49 |
| Biogen, Inc. | 2 | $40 |
| CARDIVA MEDICAL, INC. | 1 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| C2N Diagnostics, LLC | 1 | $14 |
Products named: ULTOMIRIS, VYVGART HYTRULO, LEQEMBI, OPTOWIRE, INGREZZA, VYEPTI, RELISTOR, PRECIVITYAD2.
Industry payments across AL — which companies pay providers there.
